This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

An updated view on how the commercial launch of Mycapssa (octreotide) delayed release oral capsules is progressing

Ticker(s): AMYT

Who's the expert?

Institution: Northwestern

  • Endocrinologist and adjunct professor of medicine (endocrinology) and medical education at Northwestern University Feinberg School of Medicine.
  • Manages 25 patients with acromegaly, has about 7 patients on Mycapssa
  • President and Chief Executive Officer of the Accreditation Council for Continuing Medical Education (ACCME).

Interview Goal
Discuss the 'real-world' experience with Mycapssa with an endocrinologist who has experience using it

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.